Welcome to our dedicated page for Crexendo SEC filings (Ticker: CXDO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Crexendo, Inc. filings document the formal disclosure record for its cloud communications and UCaaS software business. Recent Form 8-K reports include financial results furnished with service, software solutions and product revenue categories, operating expense metrics, net income, EBITDA and adjusted EBITDA measures.
The filing record also covers material corporate events and governance matters, including the completed acquisition of Estech Systems, LLC, a credit agreement with revolving and term-loan facilities, annual meeting voting results, director elections, advisory compensation votes, and Regulation FD investor-presentation disclosures. These filings describe Crexendo's financing arrangements, capital actions, shareholder approvals, governance structure and operating performance as a public software technology company.
Crexendo, Inc. Chief Strategy Officer Anand Buch reported open-market sales of the company’s common stock. On March 11 and March 13, 2026, he sold a total of 88,000 shares in three open-market transactions at prices between $6.35 and $6.735 per share.
Following these sales, Buch directly owns 447,498 shares of Crexendo common stock, indicating he retains a substantial equity position even after the dispositions.
Crexendo, Inc. director and 10% owner Steven G. Mihaylo reported open-market sales of a total of 64,994 shares of common stock, executed indirectly via a trust. The sales took place between March 6 and March 10, 2026 at prices ranging from $6.79 to $7.06 per share. Following these transactions, the trust’s indirect holdings stood at 11,241,771 shares of Crexendo common stock.
Crexendo, Inc. Chief Technology Officer David Tzat-kin Wang reported open-market sales of company stock. On March 9, 2026, he sold 18,606 shares of Common Stock at an average price of $7.00 per share and a further 1,876 shares at $7.01 per share.
After these transactions, Wang directly holds 629,949 shares of Crexendo common stock. The filing reflects net sales of 20,482 shares and shows no related option exercises or derivative positions in this report.
Crexendo, Inc. Chief Strategy Officer Anand Buch reported a mix of equity compensation activity and stock sales. On March 4–5, 2026, he exercised a total of 6,251 Restricted Stock Units into common shares, with 2,555 shares withheld by the company to cover payroll taxes; the footnotes clarify these tax-withholding dispositions are not sales. He also received a grant of 10,000 ISO stock options at an exercise price of $6.47 per share, vesting monthly through 2036. On March 10, 2026, Buch made open-market sales of 34,315 shares of common stock at prices of about $6.88 and $7.01 per share. After these transactions, he directly holds 535,498 shares of Crexendo common stock.
Crexendo, Inc. director Todd Andrew Goergen reported option awards and related share movements. On March 4, 2026, he was granted 10,000 stock options at $6.47 per share, vesting in 36 equal monthly installments beginning on April 4, 2026.
On September 12, 2025, he exercised 10,000 non-qualified stock options at $2.25 per share, receiving 10,000 shares of common stock and increasing his directly held common shares to 238,676 before withholding. A related tax-withholding transaction used 3,324 shares at $6.77 to cover obligations, leaving him with 235,352 common shares held directly. A footnote explains this was a net exercise in which he effectively received 6,676 shares after withholding, and it does not represent an open-market sale.
Crexendo, Inc. director David Roy Williams reported receiving a grant of stock options. The award covers 10,000 stock options with an exercise price of $6.47 per share. According to the disclosure, these options vest in 36 equal monthly installments beginning on April 4, 2026, meaning the director earns the right to exercise a portion of the options each month over three years. Following this grant, Williams is shown as holding 10,000 stock options directly.
Crexendo, Inc. director Anil K. Puri reported receiving a grant of stock options for 10,000 shares at an exercise price of $6.47 per share. This is an acquisition of derivative securities rather than an open-market stock purchase.
The options vest in 36 equal monthly installments beginning on April 4, 2026, meaning the award becomes exercisable gradually over three years, aligning Puri’s potential equity ownership with longer-term service to the company.
Crexendo, Inc. director Kevin Arnold Jackson reported receiving a grant of stock options on March 4, 2026. The award covers 10,000 stock options with an exercise price of $6.47 per share, giving him the right to buy company stock at that price in the future.
According to the filing, these options vest in 36 equal monthly installments beginning on April 4, 2026, meaning the award becomes exercisable gradually over three years rather than all at once. After this grant, he holds 10,000 stock options directly.